Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Dow Jones Today: Index Flat as Investors Mull Global Rate Decisions
05:10pm, Thursday, 22'nd Jun 2023
The Dow Jones Industrial Average closed down 0.01%, or 4 points, spending most of the day in the red as investors digested the latest moves by central banks around the world.
Amgen's (AMGN) Blincyto sBLA Gets FDA Nod in Treating Leukemia
11:06am, Thursday, 22'nd Jun 2023
Amgen (AMGN) announces full approval of its sBLA for Blincyto as an immune-oncology therapy for treating adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.
Dow Jones Today: Inflation Down, Index Up
05:10pm, Tuesday, 13'th Jun 2023
The Dow Jones Industrial Average rose 0.4%, or about 145 points, after May's inflation report encouraged investors the Federal Reserve will keep interest rates steady at least until July.
Deep Value Moments
03:57pm, Tuesday, 13'th Jun 2023
One month ago, I was privileged to speak at the London Value Investor Conference (LVIC). Fortunately for us, Ben Inker, co-head of asset allocation at Grantham Mayo Van Otterloo (GMO), kicked off the
Nicholas Ward's Dividend Growth Portfolio: April And May Review
07:50am, Tuesday, 13'th Jun 2023
My passive income stream increased by 25.59% YoY in April 2023 and 40.02% YoY in May 2023, with a year-to-date growth of 29.99%. I have been taking advantage of high yields on money market funds and s
Dow Jones Today: Index Inches Up Ahead of Fed Meeting
05:15pm, Friday, 09'th Jun 2023
The Dow Jones Industrial Average ticked up about 0.1%, or 44 points, on below-average volume as investors await next week's inflation reading and an interest rate decision from the Federal Reserve.
AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
04:00pm, Friday, 09'th Jun 2023
THOUSAND OAKS, Calif. , June 9, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 44th Annual Global Healthcare Conference at 2:20 p.m.
Amgen: Big Yield And Dividend Growth On Sale Now
11:21pm, Thursday, 08'th Jun 2023
The article analyzes Amgen's financial performance, including balance sheet trends, valuation models, and competition & margin trends. We'll discuss AMGN's dividend and free cash flow of this large, v
Is AbbVie or Amgen the Better Bargain Buy Right Now?
12:15pm, Thursday, 08'th Jun 2023
Exclusivity losses can be big setbacks for pharma companies. AbbVie and Amgen both face this key overhang.
Buy 3 June Dogs Of The Dow, Watch 4
06:44pm, Tuesday, 06'th Jun 2023
"The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.” -
U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map
12:25pm, Tuesday, 06'th Jun 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
01:17pm, Friday, 02'nd Jun 2023
Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers.
High Yield Stock Watchlist: June 2023
11:43am, Friday, 02'nd Jun 2023
There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. An equally weighted portfolio of these stocks u
Why AbbVie and Amgen Are Moving Lower Today
12:50pm, Thursday, 01'st Jun 2023
Today, Coherus and Mark Cuban announced a partnership to launch an ultra-low-priced Humira biosimilar. This steep discount might have negative consequences for both AbbVie and Amgen later on this year
Is Amgen a Good Dividend Stock?
12:00pm, Thursday, 01'st Jun 2023
Amgen ticks off most of the important boxes as a top dividend stock. However, the company is dealing with a host of important headwinds with no easy solutions.
